Long-term Study of TAK-875
NCT01433406
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1222
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus
Interventions
DRUG:
TAK-875
DRUG:
TAK-875
Sponsor
Takeda